StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PAVM

PAVmed Inc.

PAVM Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$5.50
+0.45 +8.80%

Key statistics

from XBRL data in SEC filings
Market cap
$40.0M
Revenue (TTM)
$85.0K
Net income (TTM)
-$22.8M
EPS (TTM)
$-20.15
P/E ratio
Dividend yield
Free cash flow
-$5.24M
Cash
$6.46M
Total assets
$45.4M
Gross margin
-100.0%
52-week range
$3.85 – $28.44

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change; Shareholder vote results Jun 24, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 30, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Mar 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Feb 4, 2026 8-K Other events Jan 23, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Dec 30, 2025 8-K Shareholder vote results Dec 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Other events Sep 11, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Other events Jul 30, 2025 8-K Entered a material agreement Jun 24, 2025 8-K Director or officer change; Shareholder vote results Jun 18, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Changed accountants Apr 25, 2025 8-K Entered a material agreement Apr 17, 2025 8-K Other events Apr 11, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 25, 2025 10-K Fiscal year ended 2024-12-31 Mar 24, 2025 8-K Other events Mar 10, 2025 8-K Unregistered sale of equity Feb 21, 2025 8-K Other events Feb 18, 2025 8-K Delisting notice or listing-rule failure; Unregistered sale of equity; Modified rights of security holders Jan 24, 2025 8-K Delisting notice or listing-rule failure; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Other events Jan 21, 2025 8-K Amended charter or bylaws; Shareholder vote results Jan 15, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Modified rights of security holders Nov 29, 2024 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders Nov 21, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Completed an acquisition or disposition; Delisting notice or listing-rule failure; Director or officer change; Regulation FD disclosure Sep 16, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 13, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Shareholder vote results Jun 20, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 14, 2024